Madrigal Pharmaceuticals IncKapitalflussrechnung
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 546.88 USD | 615 USD | 290 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 680 USD | 10 | 3 | 1 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 23.055.659 | 10,52 | 4,8 |
Kennzahl in 1000 USD | TTM 2026-03-31 | 2025-12-31 | 2024-12-31 | 2017-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2004-12-31 | 2003-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus operativer Geschäftstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Operative Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Investitionsausgaben (CapEx) | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Investitionstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Finanzierungstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - |
Freier Cashflow | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Freie Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - | - | - | - |